Press release
Increasing Prevalence Of Fungal Infections Fueling The Growth Of The Market Due To Rising Immunocompromised Population And Poor Hygiene: A Significant Driver Propelling The Dermatomycoses Market In 2025
Dermatomycoses
What Is the Dermatomycoses Market Size and Projected Growth Rate?
In recent years, the dermatomycoses market has seen significant expansion. It is predicted to increase from $14.12 billion in 2024 to $14.95 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. The growth observed in the historical period can be attributed to several factors including the advancement in antifungal treatments, increasing occurrence of fungal infections, growth in awareness regarding skin health, enhancing improved diagnostic techniques, and the proliferation of over-the-counter antifungal products.
Expectations are high for a significant increase in the dermatomycoses market size over the coming years. The prediction is that it will have escalated to an impressive $18.59 billion by 2029, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this projected growth include the ageing population, escalation in drug-resistant fungal strains, mounting preference for organic and natural antifungal items, advanced biotechnology and antifungal research, and increased access to healthcare in developing areas. The forecast period is expected to see notable trends such as innovative antifungal drug development, advances in quick diagnostic technology, the incorporation of artificial intelligence in dermatology, the use of nanotechnology in antifungal treatments, and innovations in microbiome-based therapies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21934
What Are the Major Segments in the Dermatomycoses Market?
The dermatomycoses market covered in this report is segmented -
1) By Drugs: Corticosteroids, Corticosteroid-Sparing Agents, Immunosuppressive, Immunomodulator, Antifungals, Other Drugs
2) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegmentss:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Corticosteroid-Sparing Agents: Tacrolimus, Pimecrolimus
3) By Immunosuppressive: Methotrexate, Azathioprine, Cyclophosphamide
4) By Immunomodulator: Interferon-Gamma, Thalidomide
5) By Antifungals: Topical Antifungals, Oral Antifungals, Systemic Antifungals
6) By Other Drugs: Antihistamines, Antibacterial Agents
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21934&type=smp
What Are The Driving Dermatomycoses Market Evolution?
The dermatomycoses market is expected to flourish due to the escalating cases of fungal infections. These infections, which affect the skin, nails, hair, or even internal organs, lead to various health problems. Extensive use of broad-spectrum antibiotics can disturb the natural microbiome, enabling fungi to proliferate and initiate infections. This imbalance weakens the body's natural defense and makes people prone to opportunistic fungal infections. Dermatomycoses, triggered by dermatophytes, yeasts, and molds, are responsible for many superficial and systemic fungal diseases, affecting many tissues. For instance, in November 2023, the UK Health Security Agency reported that worldwide, there is an annual incidence of about 6.5 million invasive fungal infections, leading to nearly 3.8 million deaths, with 2.5 million directly linked to these infections. Consequently, the growing occurrence of fungal infections is stimulating the dermatomycoses market. The dermatomycoses market is also likely to be driven by a surge in demand for oral drugs, given their accessibility and effectiveness. Oral medications, including tablets, capsules, or liquids that are ingested and absorbed through the digestive system, are increasingly desirable as they offer comfort and efficiency over injections or alternate delivery methods. Dermatomycoses support oral medications since systemic antifungal agents can enter the infected skin, hair, or nails via blood circulation, promising deeper and extended treatment versus topical applications. For example, in October 2022, the Centers for Disease Control and Prevention recorded a 57% increase in the provision of oral antivirals, rising from 643 per 100,000 persons between April 24 and May 21, 2022, to 1,012 per 100,000 persons between July 31 and August 28, 2022. Therefore, the escalating demand for oral drugs contributes to the expansion of the dermatomycoses market.
Which Firms Dominate The Dermatomycoses Market Segments?
Major companies operating in the dermatomycoses market are Pfizer Inc., Bayer AG, Saphnix Life Sciences, MITS Healthcare Private Limited, Weefsel Pharma, AdvaCare Pharma, Associated Biotech, Healthy Life Pharma Private Limited, Blueberry Therapeutics Ltd., Livealth Biopharma Pvt. Ltd., LGM Pharma, SiNi Pharma Pvt. Ltd., Joshi Agrochem Pharma Private Limited, Wellona Pharma, Abiba Pharmacia Pvt. Ltd., Vee Excel Drugs & Pharmaceuticals Pvt. Ltd., Femcorp Pharma, Lexicare Pharma Pvt. Ltd., Glamris Dermacare, Henin Lukinz
What Trends Are Expected to Dominate the Dermatomycoses Market in the Next 5 Years?
Significant players in the dermatomycoses industry are turning their attention to experimental new drug candidates as a way to advance treatment for onychomycosis and improve its effectiveness. An experimental new drug (IND) candidate is simply a medicinal compound being tested in preclinical or clinical studies to gauge its safety, effectiveness, and the likelihood of it gaining regulatory approval before becoming an officially authorized treatment. In particular, Vanda Pharmaceuticals Inc., a biopharmaceutical firm based in the US, received US Food and Drug Administration (FDA) approval for their Investigational New Drug VTR-297 candidate for treating onychomycosis in January 2024. VTR-297 stands out among topical antifungal candidates due to its histone deacetylase (HDAC) inhibitor properties, setting it apart from conventional antifungal therapies. The drug works by tackling the root of fungal growth, demonstrating significant antifungal activity against dermatophytes and other fungi. This ground-breaking approach potentially offers quicker and more effective treatment results, while also mitigating the risk of recurring infections, thus addressing a pressing unmet need in onychomycosis treatment.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/dermatomycoses-global-market-report
Which Is The Largest Region In The Dermatomycoses Market?
North America was the largest region in the dermatomycoses market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatomycoses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Dermatomycoses Market?
2. What is the CAGR expected in the Dermatomycoses Market?
3. What Are the Key Innovations Transforming the Dermatomycoses Industry?
4. Which Region Is Leading the Dermatomycoses Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Prevalence Of Fungal Infections Fueling The Growth Of The Market Due To Rising Immunocompromised Population And Poor Hygiene: A Significant Driver Propelling The Dermatomycoses Market In 2025 here
News-ID: 3987180 • Views: …
More Releases from The Business Research Company
Segmentation, Main Drivers, and Competitive Overview of the Automotive Lane Warn …
The automotive lane warning systems market is poised for substantial expansion in the coming years, driven by rapid technological advancements and increasing safety demands. As the automotive industry embraces smarter and more connected vehicles, these systems are becoming increasingly essential for enhancing road safety and supporting autonomous driving features. Let's explore the projected market size, key players, critical drivers, and the main segments shaping this evolving sector.
Projected Market Size of…
Segment Evaluation and Major Growth Areas in the Automotive Interior Market
The automotive interior market is on track for substantial growth in the coming years, driven by rapid advancements and shifting consumer preferences. As automakers continue to innovate, the interiors of vehicles are evolving to offer enhanced comfort, technology integration, and sustainability. Below, we explore the market's valuation forecast, leading players, key trends, and major segments shaping the industry's future.
Projected Growth and Market Size of the Automotive Interior Industry
The automotive…
Competitive Landscape: Key Market Leaders and New Entrants in the Automotive Hyp …
The automotive hypervisor market is rapidly evolving as vehicles become increasingly software-driven and connected. Advances in autonomous driving and cybersecurity are driving the need for sophisticated virtualization technologies. This overview explores the market's projected growth, key players shaping the landscape, emerging trends, and the main segments fueling expansion.
Automotive Hypervisor Market Size and Growth Forecast Through 2030
The automotive hypervisor market is poised for remarkable expansion, expected to reach a valuation…
Emerging Growth Trends Driving Expansion in the Automotive Human-Machine Interfa …
The automotive human-machine interfaces market is poised for substantial growth as vehicle technology rapidly evolves. With advancements in autonomous driving, electric vehicles, and smart cockpit systems, this sector is set to transform how drivers and passengers interact with their vehicles. Below is a detailed look at the market size, key players, trends driving innovation, and the main segments shaping this industry.
Automotive Human-Machine Interfaces Market Size and Growth Outlook
The automotive…
More Releases for Dermatomycoses
Dermatomycoses Market Overview, Key Trends, and Major Player Analysis
The dermatomycoses market is positioned for significant growth in the coming years, driven by advancements in treatment options and rising awareness around skin health. As fungal skin infections become more prevalent, the demand for effective therapies and enhanced dermatological care continues to expand worldwide. This overview explores the market's size, key players, emerging trends, and core segments shaping its trajectory.
Expected Market Growth and Size of the Dermatomycoses Market
The dermatomycoses…
2025-2034 Dermatomycoses Market Outlook: Key Drivers, Emerging Challenges, and S …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Dermatomycoses Industry Market Size Be by 2025?
Regarding the dermatomycoses sector, its valuation has experienced consistent expansion recently, projected to rise from $14.12 billion in 2024 to $14.81 billion the following year, reflecting a compound annual growth rate (CAGR) of 4.9%; this upswing throughout the historical…
Dermatomycoses Market is Expected to Show a Healthy Growth Rate During the Study …
(Las Vegas, Nevada, United States), DelveInsight's "Dermatomycoses - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Dermatomycoses, historical and forecasted epidemiology as well as the Dermatomycoses market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Download Sample Report to know more: @https://www.delveinsight.com/sample-request/dermatomycoses-market
Dermatomycoses Overview
Dermatomycosis is one of the most frequent fungal infections worldwide and acquired…
Global Dermatomycoses Drug Market 2020 - Anacor Pharmaceuticals Inc , Biolab Far …
Global Dermatomycoses Drug Market Survey Report: Supply, Demand, Production, Consumption, Competition, Vendors, Value Chain, Sales, Pricing, Statistical Analysis, Regional Analysis, Segments, Revenue, Volume, Historical Data, and Projections to 2025
Dermatomycoses Drug
The Dermatomycoses Drug market research report consists of a detailed analysis of the Dermatomycoses Drug market, in which major players are profiled. All the major companies engaged with the Dermatomycoses Drug market are studied. The Dermatomycoses Drug market research report…
Dermatomycoses Drug Market 2019 Global Analysis By Key Players Anacor Pharmaceut …
The global Dermatomycoses Drug market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Dermatomycoses Drug market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Dermatomycoses…
Dermatomycoses Market grows with rise in cases of fungal infections globally
Dermatomycoses is a fungal infection of the skin commonly caused by yeast, dermatophytes or other groups of fungi (e.g. epidermophyton, microsporum and genera trichophyton). These organisms break down the keratin tissues of hair, epidermis, nails and are mainly characterized by colonization of the keratinized layers on the surface of skin. Dermatomycoses commonly refers as tinea or ring-worm infections due to its characteristic ringed lesions. It comprises various types of ringworm…
